Position in SNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$156,921,480
-$36,288,076 QoQ
Shares Held
3,678,422
-8.3% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. SNY ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,921,480 | 3,678,422 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $193,209,556 | 4,010,161 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $164,773,303 | 3,400,192 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $140,362,321 | 2,973,778 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $174,109,335 | 3,604,002 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $260,321,584 | 4,693,862 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $239,376,145 | 4,963,221 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $496,633,265 | 8,617,617 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $738,196,816 | 15,214,279 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $829,599,859 | 17,069,956 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,013,455,922 | 20,379,166 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,222,785,108 | 22,796,143 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,226,179,560 | 22,749,157 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,267,017,376 | 23,282,201 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $963,495,233 | 19,894,595 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $692,114,976 | 18,203,971 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $936,314,100 | 18,715,053 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $948,809,148 | 18,480,895 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $861,977,562 | 17,205,141 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $803,962,782 | 16,676,266 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $869,943,357 | 16,520,003 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $717,884,399 | 14,514,444 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $912,896,334 | 18,787,741 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $914,545,015 | 18,228,922 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,095,072,068 | 21,450,971 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $786,386,042 | 17,986,872 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||